Cypress Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Cypress Asset Management's BIIB Position: Q1 2019 in Review
Cypress Asset Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 790 shares — an estimated $238K sold.
Cypress Asset Management first reported a position in BIIB in Q2 2014 and held it in 19 quarters. The position peaked at $1.04M in Q2 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.
- Cypress Asset Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
- Cypress Asset Management sold 790 Biogen shares in Q1 2019, an estimated $238K.
- Cypress Asset Management first reported a position in Biogen in Q2 2014 and held it in 19 quarters.
- Cypress Asset Management's Biogen position peaked at $1.04M in Q2 2015.
- 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.
Based on Cypress Asset Management's 13F filing for Q1 2019, filed 29 Apr 2019.